Re-treatment regimens for acute stage of Kawasaki disease patients who failed to respond to initial intravenous immunoglobulin therapy: Analysis from the 17th nationwide survey

Pediatrics International

Volumn 49, Issue 4, 2007, Pages 427-430

  Uehara, Ritei ^a   Yashiro, Mayumi ^a   Oki, Izumi ^a   Nakamura, Yosikazu ^a   Yanagawa, Hiroshi ^b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b SAITAMA PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Immunoglobulin; Kawasaki disease; Nationwide survey; Re treatment; Steroids; Ulinastatin

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN; STEROID; ULINASTATIN;

ACUTE DISEASE; ARTICLE; CHILD; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG MEGADOSE; DRUG TREATMENT FAILURE; HEALTH SURVEY; HOSPITAL; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MONOTHERAPY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PEDIATRICIAN; PRIORITY JOURNAL; QUESTIONNAIRE; SINGLE DRUG DOSE; TREATMENT OUTCOME;

ASPIRIN; DRUG ADMINISTRATION SCHEDULE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MUCOCUTANEOUS LYMPH NODE SYNDROME; QUESTIONNAIRES; RETREATMENT;

EID: 34250775460     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2007.02389.x     Document Type: Article

References (15)

1. Newburger JW, Takahashi M, Beiser AS et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N. Engl. J. Med. 1991 324 : 1633 9.
2. Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 2000 105 : e78.
3. Hashino K, Ishii M, Iemura M, Akagi T, Kato H. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr. Int. 2001 43 : 211 17.
4. Sundel RP, Burns JC, Baker A, Beiser AS, Newburger JW. Gamma globulin re-treatment in Kawasaki disease. J. Pediatr. 1993 123 : 657 9.
5. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. Pediatr. Infect. Dis. J. 1998 17 : 1144 8.
6. Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J. Pediatr. 1996 128 : 146 9.
7. Nakano M, Yamada S, Hayashi Y, Morishita M, Iwaki T, Toyoda M. Preventive effects of ulinastatin for coronary artery aneurysm formation in Kawasaki disease. In : Kato H (ed Kawasaki Disease. Elsevier Science, Amsterdam, 1995 364 71.
8. Okada M, Ogino D, Abe A, Ikeda H. Treatment with ulinastatin in the patients with gamma globulin resistant Kawasaki disease. Prog. Med. 2002 22 : 2755 61.
9. Mori M, Imagawa T, Katakura S et al. Efficacy of plasma exchange therapy for Kawasaki disease intractable to intravenous gamma-globulin. Mod. Rheumatol. 2004 14 : 43 7.
10. Newburger JW, Takahashi M, Gerber MA et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004 110 : 2747 71.
11. Saji T, Sonobe T, Uemura S, Akagi T, Ayusawa M The guideline for treatment for acute Kawasaki disease in Japan; A statement for health professional from the research committee of Japanese society of Pediatric Cardiology and Cardiac Surgery J. Jpn. Pediatr. Soc. 2003 107 : 1713 15 (in Japanese).
12. Akagi T, Kato H, Inoue O, Sato N. Salicylate treatment in Kawasaki disease: high dose or low dose? Eur. J. Pediatr. 1991 150 : 642 6.
13. Yashiro M, Uehara R, Oki I. et al Yearly changes in gamma globulin treatment for Kawasaki disease patients, 1993-2002 J. Jpn. Pediatr. Soc. 2004 108 : 1461 6 (in Japanese).
14. Oates-Whitehead RM, Baumer JH, Haines L et al. Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst. Rev. 2003 4 CD004000.
15. Ogino H, Okamoto S, Fujiwara T, Nakayama Y, Yashiro M, Yanagawa H Relationship between the coronary arterial lesions and immunoglobulin therapy, in particular the initial dose and the day of illness, in Kawasaki disease J. Jpn. Pediatr. Soc. 2003 107 : 1506 13 (in Japanese).